US filing analysis · 10-Q
Sorted by SEC acceptance time (filing date when unavailable). Page 18 · 30 shown · up to 30 per page
REGN
Regeneron Pharmaceuticals said net product sales of EYLEA HD increased for the 3 and 9 months ended 2025 due to higher sales volumes, partly offset by a lower net selling price. It said net product sales of EYLEA were impacted by lower sales volumes and a lower net selling price.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 28, 2025
Regeneron PharmaceuticalsREGN$920.76-0.28%
RCL
Royal Caribbean Group said Net Income attributable to Royal Caribbean Cruises Ltd. and Adjusted Net Income attributable to Royal Caribbean Cruises Ltd. for Q3 2025 were $1.6 billion, respectively, and total revenues increased $253 million to $5.1 billion.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 28, 2025
Royal Caribbean GroupRCL$296.48-2.20%
PYPL
PayPal said net revenues for the 3 months ended September 30, 2025 increased $570 million, or 7%, compared to the same period of the prior year, operating income increased $129 million, or 9%, and net income increased $238 million, or 24%. Operating margin was 18% for both periods.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 28, 2025
PayPalPYPL$53.31-5.43%
PLD
Prologis said that as of September 30, 2025, its total available liquidity was $7.5 billion, the weighted average remaining maturity of its consolidated debt was 9 years and the weighted average interest rate was 3.2%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 12, 2026 (UTC)SEC filing date Oct 28, 2025
PrologisPLD$122.5-0.70%
NXPI
NXP said revenue for the quarter ended September 28, 2025 was $3,173 million, a decrease of 2.4% compared to $3,250 million in the year-ago period, and GAAP gross margin was 56.3%, compared to 57.4% in the year-ago period.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Oct 28, 2025
NXP SemiconductorsNXPI$235.48-6.47%
MSCI
MSCI said total operating revenues for the quarter ended September 30, 2025 increased 9.5% (9.0% adjusting for foreign currency exchange rate fluctuations), and Index segment operating revenues increased 11.4%. Index segment asset-based fees increased 17.1%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 28, 2025
MSCIMSCI$619.23-0.82%
MDLZ
Mondelez International said net revenues for Q3 2025 increased $540 million (5.9%) to $9,744 million, and Organic Net Revenue increased $316 million (3.4%) to $9,520 million. The company said higher net pricing was partially offset by unfavorable volume/mix.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Oct 28, 2025
Mondelez InternationalMDLZ$66.3+0.93%
KDP
Keurig Dr Pepper said gross profit for Q3 2025 increased 9.3% to $2,340 million, income from operations increased 10.3% to $995 million, and net income increased 7.5% to $662 million. Diluted earnings per share were $0.49.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 28, 2025
Keurig Dr PepperKDP$34.85+1.28%
HBAN
Huntington reported net income of $629 million, or $0.41 per diluted common share, for Q3 2025, compared with net income of $517 million, or $0.33 per diluted common share, in the year-ago quarter.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 28, 2025
Huntington BancsharesHBAN$14.29-2.86%
BRO
Brown & Brown said commissions and fees for the quarter ended September 30, 2025 increased $395 million from the same period in the prior year to $1,550 million, a 34.2% increase. The company said the Organic Revenue growth rate was 3.5% and acquisitions generated $307 million.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 28, 2025
Brown & BrownBRO$73.07+1.00%
AVY
Avery Dennison said net income decreased from approximately $531 million in the first 9 months of 2024 to approximately $522 million in the first 9 months of 2025, citing the net impact of raw material deflation-related price reductions, higher provision for income taxes and growth investments as primary factors.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 28, 2025
Avery DennisonAVY$181.15-1.09%
AOS
A. O. Smith said sales for Q3 2025 were $942.5 million, higher than Q3 2024 sales of $902.6 million, and gross profit margin was 38.7%, up from 37.4% in the prior-year quarter. The company cited pricing actions implemented earlier in the year in North America as a driver of the margin increase.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 28, 2025
A. O. SmithAOS$63.24-0.74%
CB
Chubb said net income attributable to Chubb for Q3 2025 was $2.8 billion, compared with $2.3 billion in the prior year period. The company said consolidated net premiums written were $14.87 billion, up 7.5%, or 6.8% in constant dollars.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 27, 2025
ChubbCB$371.63+0.41%
ARE
Alexandria Real Estate Equities said income from rentals for the 3 months ended September 30, 2025 decreased to $735.8 million, a decline of $39.9 million (5.1%). Same Properties' average occupancy was 91.4% for the period, compared to 94.8% in the prior-year period.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 27, 2025
Alexandria Real Estate EquitiesARE$40.2-3.76%
STLD
Steel Dynamics said consolidated operating income for Q3 2025 increased $112.3 million, or 28%, to $507.8 million compared with the same period in the prior year. Net income attributable to the company increased $85.9 million, or 27%, to $403.7 million.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 24, 2025
Steel DynamicsSTLD$205.96-5.64%
PG
Procter & Gamble said net sales for the quarter ended September 30, 2025 were $22.4 billion, an increase of $649 million, or 3%, and net earnings increased 20% to $4.8 billion. The company cited higher restructuring charges related to the substantial liquidation of operations in Argentina and other Enterprise Markets in the prior year period as a factor in the increase in net earnings.
US filing analysisUS10-Q · Quarterly reportPublished Oct 12, 2026 (UTC)SEC filing date Oct 24, 2025
Procter & GamblePG$169.37+0.91%
LVS
Las Vegas Sands recorded net revenues of $3.33 billion, operating income of $719 million and net income of $491 million for the 3 months ended September 30, 2025, compared to $2.68 billion, $504 million and $353 million, respectively, for the same period in 2024.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 24, 2025
Las Vegas SandsLVS$38.85-1.22%
JBHT
J.B. Hunt said consolidated operating revenues for Q3 2025 were $3.05 billion, a 0.5% decrease from $3.07 billion in Q3 2024, and operating income increased to $242.7 million from $224.1 million in 2024.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 24, 2025
J.B. HuntJBHT$218.54-3.03%
DOC
Healthpeak cited other-than-temporary impairment charges on two lab unconsolidated joint ventures, a decrease in gain on sales of real estate related to fewer real estate dispositions, and an increase in interest expense as factors in the decrease in net income applicable to common shares for Q3 2025.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 24, 2025
Healthpeak PropertiesDOC$19.24+0.26%
BKR
Baker Hughes said Q3 2025 revenue was $7.0 billion, an increase of $0.1 billion, or 1%, compared to Q3 2024. IET revenue increased $0.4 billion, or 15%, and OFSE revenue decreased $0.3 billion, or 8%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 12, 2026 (UTC)SEC filing date Oct 24, 2025
Baker HughesBKR$44.85-3.90%
WST
West Pharmaceutical Services said consolidated net sales for the 3 months ended September 30, 2025 increased by $57.7 million, or 7.7%, compared with the same period in the prior year. Excluding foreign currency translation effects, consolidated net sales increased by $37.6 million, or 5.0%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 23, 2025
West Pharmaceutical ServicesWST$390.3-1.61%
VRSN
Verisign said revenues for the 3 and 9 months ended September 30, 2025 were $419.1 million and $1,231.3 million, respectively, representing increases of 7% and 6% compared to the same periods in the prior year. Operating income for the same periods was $284.3 million and $836.2 million, respectively, representing increases of 6% and 5%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Oct 23, 2025
VerisignVRSN$306.97+0.17%
TXT
Textron said revenues for Q3 2025 increased $175 million, or 5%, compared with Q3 2024. Textron Aviation revenues rose $138 million, Bell revenues increased $97 million, Textron Systems revenues grew $6 million, and Industrial revenues declined $79 million.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Oct 23, 2025
TextronTXT$79.62-1.85%
TXN
Texas Instruments said third-quarter revenue was $4.74 billion, net income was $1.36 billion and earnings per share were $1.48. Revenue increased 7% sequentially and 14% from the year-ago quarter, with growth across all end markets.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 23, 2025
Texas InstrumentsTXN$263.75-7.70%
TMUS
T-Mobile said total revenues for the 3 months ended September 30, 2025 increased $1.8 billion (9%) and for the 9 months increased $4.4 billion (7%). Postpaid revenues increased $1.6 billion (12%) for the 3 months and $3.7 billion (10%) for the 9 months.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 23, 2025
T-Mobile USTMUS$165.6+1.89%
PCG
The company said the Utility's electric and natural gas operating revenues increased by $309 million (5%) in the 3 months ended September 30, 2025 and by $343 million (2%) in the 9 months ended the same date, compared to the same periods in the prior year. The company cited approximately $150 million in revenues to recover costs associated with extended operations at DCPP in the 3 months as a factor in the increase.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 23, 2025
PG&EPCG$13.78-1.15%
NDAQ
Nasdaq said U.S. operating companies raised $6.0 billion in proceeds through listings in Q3, its Index business recorded net inflows of $17 billion in Q3 and $91 billion over the last 12 months.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Oct 23, 2025
NasdaqNDAQ$103.01-0.90%
MCO
Moody's said total revenue for the 3 months ended September 30, 2025 increased 11%, with MA growing 9% and MIS growing 12%, and organic constant currency revenue increasing 9%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 23, 2025
Moody'sMCO$466.83-1.06%
KO
The Coca-Cola Company said net operating revenues for the 3 months ended September 26, 2025 were $12,455 million, an increase of $601 million, or 5%, compared to $11,854 million in the same period of the prior year.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 23, 2025
The Coca-Cola CompanyKO$96.8+0.74%
IBM
IBM said that in Q3 2025 it reported revenue of $16.3 billion, net income from continuing operations of $1.7 billion, and operating (non-GAAP) earnings of $2.5 billion, with diluted earnings per share from continuing operations of $1.84 as reported and $2.65 on an operating (non-GAAP) basis.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Oct 23, 2025
IBMIBM$224.44+0.25%
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.